Terms: = Liver cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
494 results:
1. CDK4/6 inhibition sensitizes MEK inhibition by inhibiting cell cycle and proliferation in pancreatic ductal adenocarcinoma.
Cheng K; Zhou Z; Chen Q; Chen Z; Cai Y; Cai H; Wu S; Gao P; Cai Y; Zhou J; Wang X; Wu Z; Peng B
Sci Rep; 2024 Apr; 14(1):8389. PubMed ID: 38600093
[TBL] [Abstract] [Full Text] [Related]
2. The P53-P21-rb1 pathway promotes BRD4 degradation in liver cancer through USP1.
Li N; Zhang E; Li Z; Lv S; Zhao X; Ke Q; Zou Q; Li W; Wang Y; Guo H; Song T; Sun L
J Biol Chem; 2024 Mar; 300(3):105707. PubMed ID: 38309505
[TBL] [Abstract] [Full Text] [Related]
3. Preliminary exploration of hepatic parenchymal near-infrared fluorescence imaging technique via retrograde biliary approach: a feasibility study (with video).
Gao F; Xie Q; Zhao X; Yang M; Jiang K; Zhang L; Mao T; Wu H
Sci Rep; 2024 Jan; 14(1):2380. PubMed ID: 38286815
[TBL] [Abstract] [Full Text] [Related]
4. Interplay of oxidative stress, cellular communication and signaling pathways in cancer.
Iqbal MJ; Kabeer A; Abbas Z; Siddiqui HA; Calina D; Sharifi-Rad J; Cho WC
Cell Commun Signal; 2024 Jan; 22(1):7. PubMed ID: 38167159
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Analysis of METTLs (METTL1/13/18/21A/23/25/2A/2B/5/6/9) and Associated mRNA Risk Signature in Hepatocellular Carcinoma.
Wang H; Hu S; Nie J; Qin X; Zhang X; Wang Q; Li JZ
Anal Cell Pathol (Amst); 2023; 2023():6007431. PubMed ID: 38130905
[TBL] [Abstract] [Full Text] [Related]
6. Discovery and Evaluation of C6-Substituted Pyrazolopyrimidine-Based Bisphosphonate Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase and Evaluation of Their Antitumor Efficacy in Multiple Myeloma, Pancreatic Ductal Adenocarcinoma, and Colorectal cancer.
Boutin R; Lee HF; Guan TL; Nguyen TT; Huang XF; Waller DD; Lu J; Christine Chio II; Michel RP; Sebag M; Tsantrizos YS
J Med Chem; 2023 Dec; 66(23):15776-15800. PubMed ID: 37982711
[TBL] [Abstract] [Full Text] [Related]
7. Multi-cohort validation study of a four-gene signature for risk stratification and treatment response prediction in hepatocellular carcinoma.
Liu C; Xiao Z; Wu S; Yang Z; Ji G; Duan J; Zhou T; Cao J; Liu X; Xu F
Comput Biol Med; 2023 Dec; 167():107694. PubMed ID: 37956625
[TBL] [Abstract] [Full Text] [Related]
8. [Inhibition of CD36 and Nogo-B expression inhibited the proliferation and migration of triple negative breast cancer cells].
Wang C; Han J; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):4168-4188. PubMed ID: 37877398
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of multi-omics data reveals inhibition of rb1 signaling promotes apatinib resistance of hepatocellular carcinoma.
He K; An S; Liu F; Chen Y; Xiang G; Wang H
Int J Biol Sci; 2023; 19(14):4511-4524. PubMed ID: 37781033
[TBL] [Abstract] [Full Text] [Related]
10. Research progress on the pharmacological effects and chemical constituents of Pien Tze Huang and its potential Q-markers.
Dong Z; Wang H; Wang G
Chin J Nat Med; 2023 Sep; 21(9):658-669. PubMed ID: 37777316
[TBL] [Abstract] [Full Text] [Related]
11. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
12. Depleted hexokinase1 and lack of AMPKα activation favor OXPHOS-dependent energetics in retinoblastoma tumors.
Babu VS; Mallipatna A; Dudeja G; Shetty R; Nair AP; Tun SBB; Ho CEH; Chaurasia SS; Bhattacharya SS; Verma NK; Lakshminarayanan R; Guha N; Heymans S; Barathi VA; Ghosh A
Transl Res; 2023 Nov; 261():41-56. PubMed ID: 37419277
[TBL] [Abstract] [Full Text] [Related]
13. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract] [Full Text] [Related]
14. NET G3 vs NEC: p53 and rb1 Immunolabeling in High-grade Gastrointestinal Neuroendocrine Neoplasms - Is It Enough for the Differential Diagnosis?
Dinu A; Aschie M; Cozaru GC; Mitroi AF; Grasa CN; Iordache IE; Deacu M; Orasanu CI; Nicolau AA; Baltatescu GI
J Gastrointestin Liver Dis; 2023 Jun; 32(2):162-169. PubMed ID: 37345605
[TBL] [Abstract] [Full Text] [Related]
15. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.
Chavda V; Zajac KK; Gunn JL; Balar P; Khadela A; Vaghela D; Soni S; Ashby CR; Tiwari AK
Cancer Rep (Hoboken); 2023 Sep; 6 Suppl 1(Suppl 1):e1821. PubMed ID: 37344125
[TBL] [Abstract] [Full Text] [Related]
16. Fully Automated, Fast Motion Correction of Dynamic Whole-Body and Total-Body PET/CT Imaging Studies.
Shiyam Sundar LK; Lassen ML; Gutschmayer S; Ferrara D; Calabrò A; Yu J; Kluge K; Wang Y; Nardo L; Hasbak P; Kjaer A; Abdelhafez YG; Wang G; Cherry SR; Spencer BA; Badawi RD; Beyer T; Muzik O
J Nucl Med; 2023 Jul; 64(7):1145-1153. PubMed ID: 37290795
[TBL] [Abstract] [Full Text] [Related]
17. Melt Polycondensation Strategy for Amide-Functionalized l-Aspartic Acid Amphiphilic Polyester Nano-assemblies and Enzyme-Responsive Drug Delivery in cancer Cells.
Khuddus M; Jayakannan M
Biomacromolecules; 2023 Jun; 24(6):2643-2660. PubMed ID: 37186892
[TBL] [Abstract] [Full Text] [Related]
18. Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast cancer: A Retrospective Real-World Biomarker Analysis.
Gerratana L; Davis AA; Velimirovic M; Reduzzi C; Clifton K; Bucheit L; Hensing WL; Shah AN; Pivetta T; Dai CS; D'Amico P; Wehbe F; Medford A; Wander SA; Gradishar WJ; Behdad A; Ma CX; Puglisi F; Bardia A; Cristofanilli M
JCO Precis Oncol; 2023 May; 7():e2200531. PubMed ID: 37141549
[TBL] [Abstract] [Full Text] [Related]
19. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
Wen S; Zeng J; Zhong L; Ye J; Lai X
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and characterization of a novel cancer stem-like cell of cholangiocarcinoma.
Panawan O; Silsirivanit A; Chang CH; Putthisen S; Boonnate P; Yokota T; Nishisyama-Ikeda Y; Detarya M; Sawanyawisuth K; Kaewkong W; Muisuk K; Luang S; Vaeteewoottacharn K; Kariya R; Yano H; Komohara Y; Ohta K; Okada S; Wongkham S; Araki N
Cancer Sci; 2023 Aug; 114(8):3230-3246. PubMed ID: 37026527
[TBL] [Abstract] [Full Text] [Related]
[Next]
